Allergan, Inc. (AGN) - Product Pipeline Analysis
Summary
Allergan, Inc. (Allergan) is a global healthcare company. It is involved in the development and commercialization of novel pharmaceuticals, over-the-counter (OTC) products, biologics and the medical devices. The company operates in two reportable segments, namely, specialty pharmaceuticals and medical devices. The specialty pharmaceutical segment produces a comprehensive range of pharmaceuticals including both prescription and OTC drugs in the areas of eye care, neuro-modulators, skin care and urologics. The medical devices segment is focused on producing devices in the areas of breast implants, facial aesthetics and obesity intervention products. The company sells its products in over 100 countries through a network of distributors and direct subsidiaries. The key customers of the company are wholesalers, drug stores, pharmacies, hospitals, and medical practitioners. Allergan is headquartered in Irvine, California, the US.
The company focuses on expanding its product range in the existing and specialty areas through inorganic and organic approaches. This intent is reflected from the company’s recent agreements with Moelcular Partners AG and MAP Pharmaceuticals besides development of Botox its lead product its lead product in different indications. The company also concentrates on increasing its presence in emerging markets as indicated by 17% growth in sales to emerging markets.
This report is a source for data, analysis and actionable intelligence on the Allergan, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to Buy
Summary
Allergan, Inc. (Allergan) is a global healthcare company. It is involved in the development and commercialization of novel pharmaceuticals, over-the-counter (OTC) products, biologics and the medical devices. The company operates in two reportable segments, namely, specialty pharmaceuticals and medical devices. The specialty pharmaceutical segment produces a comprehensive range of pharmaceuticals including both prescription and OTC drugs in the areas of eye care, neuro-modulators, skin care and urologics. The medical devices segment is focused on producing devices in the areas of breast implants, facial aesthetics and obesity intervention products. The company sells its products in over 100 countries through a network of distributors and direct subsidiaries. The key customers of the company are wholesalers, drug stores, pharmacies, hospitals, and medical practitioners. Allergan is headquartered in Irvine, California, the US.
The company focuses on expanding its product range in the existing and specialty areas through inorganic and organic approaches. This intent is reflected from the company’s recent agreements with Moelcular Partners AG and MAP Pharmaceuticals besides development of Botox its lead product its lead product in different indications. The company also concentrates on increasing its presence in emerging markets as indicated by 17% growth in sales to emerging markets.
This report is a source for data, analysis and actionable intelligence on the Allergan, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Allergan, Inc. - Business Description
Key Facts
Allergan, Inc. - Major Products and Services
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Trial Phase
Brimonidine PLGA Intravitreal Implant
Brimonidine PLGA Intravitreal Implant Product Status
Brimonidine PLGA Intravitreal Implant Product Description
Juvederm VOLUMA
Juvederm VOLUMA Product Status
Juvederm VOLUMA Product Description
Juvederm VOLUMA Product Patent Details
Natrelle Style 410
Natrelle Style 410 Product Status
Natrelle Style 410 Product Description
Natrelle Style 410 Product Patent Details
ORBERA Intragastric Balloon System
ORBERA Intragastric Balloon System Product Status
ORBERA Intragastric Balloon System Product Description
ORBERA Intragastric Balloon System Product Patent Details
Allergan, Inc. - Key Competitors
Allergan, Inc. - Key Employees
Allergan, Inc. - Key Employee Biographies
Allergan, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Allergan, Inc., Recent Developments
May 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q1 2012
Mar 12, 2012: Allergan Confirms Favorable Decision Of US Federal Court And Issuance Of Permanent Injunction Against Merz
Feb 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q4 2011
Dec 23, 2011: Allergan Reassures Patients And Surgeons Of The Quality And Safety Of Its Breast Implant Devices Sold And Distributed Worldwide
Nov 24, 2011: Allergan Launches INSPIRA Gel-Filled Breast Implants In Canada
Nov 08, 2011: Allergan To Open New Research And Development Facility In New Jersey
Oct 26, 2011: Allergan Reports Revenues Of $1.3 Billion In Q3 2011
Aug 03, 2011: Allergan Reports Total Revenue Of $1.4 Billion In Q2 2011
Jun 22, 2011: Study Analysis Demonstrates Gastric Banding Is Safe And Cost-Effective Weight-Loss Surgery Procedure: Allergan
May 04, 2011: Allergan Reports Revenues Of $1.3 Billion In Q1 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Allergan, Inc., Key Facts
Allergan, Inc. Key Pipeline Products by Equipment Type
Allergan, Inc. Key Pipeline Products by Therapy Area
Allergan, Inc. Key Pipeline Products by Development Stage
Allergan, Inc. Key Pipeline Products by Trial Phase
Allergan, Inc., Key Facts
Allergan, Inc., Major Products and Services
Allergan, Inc. Number of Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Number of Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Number of Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Number of Pipeline Products by Trial Phase
Allergan, Inc. Pipeline Products by Trial Phase
Brimonidine PLGA Intravitreal Implant - Product Status
Brimonidine PLGA Intravitreal Implant - Product Description
Juvederm VOLUMA - Product Status
Juvederm VOLUMA - Product Description
Juvederm VOLUMA - Patent Details
Natrelle Style 410 - Product Status
Natrelle Style 410 - Product Description
Natrelle Style 410 - Patent Details
ORBERA Intragastric Balloon System - Product Status
ORBERA Intragastric Balloon System - Product Description
ORBERA Intragastric Balloon System - Patent Details
Allergan, Inc., Key Employees
Allergan, Inc., Key Employee Biographies
Allergan, Inc., Other Locations
Allergan, Inc., Subsidiaries
LIST OF FIGURES
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Trial Phase
Key Facts
Allergan, Inc. - Major Products and Services
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Trial Phase
Brimonidine PLGA Intravitreal Implant
Brimonidine PLGA Intravitreal Implant Product Status
Brimonidine PLGA Intravitreal Implant Product Description
Juvederm VOLUMA
Juvederm VOLUMA Product Status
Juvederm VOLUMA Product Description
Juvederm VOLUMA Product Patent Details
Natrelle Style 410
Natrelle Style 410 Product Status
Natrelle Style 410 Product Description
Natrelle Style 410 Product Patent Details
ORBERA Intragastric Balloon System
ORBERA Intragastric Balloon System Product Status
ORBERA Intragastric Balloon System Product Description
ORBERA Intragastric Balloon System Product Patent Details
Allergan, Inc. - Key Competitors
Allergan, Inc. - Key Employees
Allergan, Inc. - Key Employee Biographies
Allergan, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Allergan, Inc., Recent Developments
May 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q1 2012
Mar 12, 2012: Allergan Confirms Favorable Decision Of US Federal Court And Issuance Of Permanent Injunction Against Merz
Feb 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q4 2011
Dec 23, 2011: Allergan Reassures Patients And Surgeons Of The Quality And Safety Of Its Breast Implant Devices Sold And Distributed Worldwide
Nov 24, 2011: Allergan Launches INSPIRA Gel-Filled Breast Implants In Canada
Nov 08, 2011: Allergan To Open New Research And Development Facility In New Jersey
Oct 26, 2011: Allergan Reports Revenues Of $1.3 Billion In Q3 2011
Aug 03, 2011: Allergan Reports Total Revenue Of $1.4 Billion In Q2 2011
Jun 22, 2011: Study Analysis Demonstrates Gastric Banding Is Safe And Cost-Effective Weight-Loss Surgery Procedure: Allergan
May 04, 2011: Allergan Reports Revenues Of $1.3 Billion In Q1 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Allergan, Inc., Key Facts
Allergan, Inc. Key Pipeline Products by Equipment Type
Allergan, Inc. Key Pipeline Products by Therapy Area
Allergan, Inc. Key Pipeline Products by Development Stage
Allergan, Inc. Key Pipeline Products by Trial Phase
Allergan, Inc., Key Facts
Allergan, Inc., Major Products and Services
Allergan, Inc. Number of Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Number of Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Number of Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Number of Pipeline Products by Trial Phase
Allergan, Inc. Pipeline Products by Trial Phase
Brimonidine PLGA Intravitreal Implant - Product Status
Brimonidine PLGA Intravitreal Implant - Product Description
Juvederm VOLUMA - Product Status
Juvederm VOLUMA - Product Description
Juvederm VOLUMA - Patent Details
Natrelle Style 410 - Product Status
Natrelle Style 410 - Product Description
Natrelle Style 410 - Patent Details
ORBERA Intragastric Balloon System - Product Status
ORBERA Intragastric Balloon System - Product Description
ORBERA Intragastric Balloon System - Patent Details
Allergan, Inc., Key Employees
Allergan, Inc., Key Employee Biographies
Allergan, Inc., Other Locations
Allergan, Inc., Subsidiaries
LIST OF FIGURES
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Therapy Area
Allergan, Inc. Pipeline Products by Trial Phase
